Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Chemo-Oil combo shows promise for liver cancer patients who Can't have surgery

NCT ID NCT07493070

First seen Mar 30, 2026 · Last updated May 23, 2026 · Updated 11 times

Summary

This study tests a new, more stable mixture of chemotherapy drug and iodized oil for treating early-stage liver cancer in people who cannot or choose not to have surgery. The treatment combines TACE (a procedure that blocks the tumor's blood supply and delivers chemo directly) with thermal ablation (using heat to destroy cancer cells). The goal is to see if this approach can completely eliminate the tumor without the need for ongoing medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Department of Interventional Radiology, Fujian Medical University Union Hospital

    Fuzhou, Fujian, 350001, China

Conditions

Explore the condition pages connected to this study.